129 related articles for article (PubMed ID: 7184433)
1. [Phase II study of carmofur (HCFU) fine granules].
Koyama Y
Gan To Kagaku Ryoho; 1982 May; 9(5):906-14. PubMed ID: 7184433
[TBL] [Abstract][Full Text] [Related]
2. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer.
Ito K; Yamaguchi A; Miura K; Kato T; Baba S; Matsumoto S; Ishii M; Takagi H
J Surg Oncol; 1996 Oct; 63(2):107-11. PubMed ID: 8888803
[TBL] [Abstract][Full Text] [Related]
3. Oral carmofur in advanced gastrointestinal cancer.
Gröhn P; Heinonen E; Kumpulainen E; Länsimies H; Lantto A; Salmi R; Pyrhönen S; Numminen S
Am J Clin Oncol; 1990 Dec; 13(6):477-9. PubMed ID: 2239802
[TBL] [Abstract][Full Text] [Related]
4. [Joint clinical Phase II study of SF-SP].
Sato T; Sato H; Hanatani Y
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1210-7. PubMed ID: 6428321
[TBL] [Abstract][Full Text] [Related]
5. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.
Nakamura T; Ohno M; Tabuchi Y; Kamigaki T; Fujii H; Yamagishi H; Kuroda Y;
Int J Oncol; 2001 Aug; 19(2):291-8. PubMed ID: 11445841
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of a new antitumor drug, 1-hexylcarbamoyl-5-fluorouracil (HCFU), administered orally: an HCFU clinical study group report.
Koyama Y; Koyama Y
Cancer Treat Rep; 1980; 64(8-9):861-7. PubMed ID: 7448823
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376
[TBL] [Abstract][Full Text] [Related]
8. Modulation by l-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinomas serially transplanted into nude mice.
Kubota T; Kase S; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Nishibori H; Ishibiki K; Kitajima M; Mabuchi K
Anticancer Res; 1992; 12(5):1549-53. PubMed ID: 1444220
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of oral carmofur in advanced pancreatic carcinoma.
Kajanti MJ; Pyrhönen SO
Ann Oncol; 1991; 2(10):765-6. PubMed ID: 1801884
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of HCFU absorption after resection for gastric cancer--application of hydroxyaluminium gel].
Kageyama T; Toizumi A; Tamura Y
Gan To Kagaku Ryoho; 2001 Jun; 28(6):803-7. PubMed ID: 11432348
[TBL] [Abstract][Full Text] [Related]
11. [Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
Nakatsu T; Takahashi H; Furue H
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3114-8. PubMed ID: 3674897
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the therapeutic effect of HCFU (1-hexylcarbamoyl-5-fluorouracil) on non-resectable stomach cancer].
Sato H; Satoh H; Isono K; Onoda S; Okuyama K; Tounosu N; Yamamoto Y; Kimura M; Chin F; Kouzu T; Ryu M; Hirasawa H
Gan To Kagaku Ryoho; 1982 Jan; 9(1):103-8. PubMed ID: 7184358
[TBL] [Abstract][Full Text] [Related]
13. [Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group].
Urushizaki I; Kogo Y; Kouda K; Ishitani K; Niitsu Y; Matsuda M; Gocho Y; Koyama R; Nagai T; Saijo N
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2358-64. PubMed ID: 3000300
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effect of HCFU therapy of head and neck cancer].
Taketa C
Gan To Kagaku Ryoho; 1986 May; 13(5):1846-50. PubMed ID: 3707146
[TBL] [Abstract][Full Text] [Related]
16. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of HCFU in combination with irradiation therapy in squamous cell carcinoma of the head and neck].
Harada T; Yamagiwa M; Kubo M; Ito Y; Fukukita K; Sakakura Y
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2538-43. PubMed ID: 3740856
[TBL] [Abstract][Full Text] [Related]
18. [A randomized controlled trial comparing short-term MF chemotherapy with MF plus long-term HCFU chemotherapy as an adjuvant to a curative resection of stomach cancer: Mifurol Study Group for Stomach Cancer].
Yamamura Y; Nakazato H; Koike A; Ichihashi H
Gan No Rinsho; 1988 Nov; 34(14):1936-42. PubMed ID: 3144615
[TBL] [Abstract][Full Text] [Related]
19. [Clinical effects of carmofur (Mifurol) on advanced and recurrent breast cancer in a cooperative study. Research association for re-evaluation of direct effects of Mifurol on breast cancer].
Kusama M; Tominaga T; Enomoto K; Yoshida M; Koyama H; Sonoo H; Takashima S; Abe R; Nishi T; Yamaguchi S
Gan To Kagaku Ryoho; 1995 Mar; 22(4):467-75. PubMed ID: 7887639
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (interim report).
Niimoto M; Hattori T; Tamada R; Sugimachi K; Inokuchi K; Ogawa N
Jpn J Surg; 1987 Sep; 17(5):354-61. PubMed ID: 3123756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
